PPARG and mucopolysaccharidosis: To further elucidate the effect of PPAR-γ in PA-induced Mps, we treated BMDMs with either the PPAR-γ agonist GW1929, the PPAR-γ antagonist GW9662, or a combination of PA with either GW1929 or GW9662.